Skip to main content

Hematology

Coagulation Analyzers

In the Hemostasis section of the clinical laboratory, the primary objective of instrumentation is to detect the conversion of Fibrinogen to Fibrin (clot formation) or to quantify the activity of specific coagulation factors. Unlike Hematology cell counters which focus on particle sizing, Coagulation analyzers focus on reaction kinetics. The evolution of these instruments has moved from manual “tilt-tube” methods to semi-automated fibrometers, and finally to fully automated high-throughput systems that employ multiple detection methodologies simultaneously

Principles of Clot Detection

The defining characteristic of any coagulation analyzer is how it determines that a clot has formed. There are two dominant methodologies in the industry: Photo-optical detection and Electromechanical detection. A competent laboratory scientist must understand which method their lab uses, as it dictates how interferences (like lipemia) are handled

Photo-Optical Detection (Turbidimetric)

This is the most common methodology used in high-volume analyzers (e.g., Sysmex CA/CS series, IL ACL TOP). It relies on the change in optical density (OD) of the plasma

  • Mechanism
    • Plasma is dispensed into a cuvette, and a specific wavelength of light is passed through it
    • Reagents (e.g., Thromboplastin + Calcium) are added to initiate the cascade
    • Initially, the plasma is clear, and light transmission is high
    • As the reaction progresses, soluble Fibrinogen converts to insoluble fibrin strands. These strands scatter light and make the solution cloudy (turbid)
    • Endpoint: The instrument detects the sudden decrease in light transmission (or increase in absorbance). The time elapsed between reagent addition and this optical change is the clotting time (PT or PTT)
  • Advantages: It enables the generation of “Clot Curves” (reaction kinetics) which provide data beyond just the time (e.g., fibrinogen concentration derived from the PT curve)
  • Limitations: It is highly sensitive to optical interferences. Lipemia (fatty plasma) and Icterus (high bilirubin) can obscure the optical reading, causing “No Clot Detected” errors or erratic baselines

Electromechanical Detection (Viscosity-Based)

This methodology is historically associated with the “Fibrometer” and currently the standard for Diagnostica Stago instruments. It measures the physical change in the viscosity of the sample

  • Mechanism (The Ball Method)
    • Plasma is placed in a cuvette containing a small steel ball
    • The cuvette is placed in a magnetic field that causes the ball to oscillate (move side-to-side) at a constant amplitude
    • Reagents are added. As fibrin strands form, the viscosity of the plasma increases
    • Endpoint: The forming clot physically restricts the movement of the steel ball. Sensors detect the decrease in the amplitude of the ball’s swing. When the movement drops below a certain threshold, the timer stops
  • Advantages: This is considered the “Gold Standard” for problematic samples. Because it relies on magnetism and physical resistance, it is unaffected by Lipemia or Icterus. It will accurately clot even in “milkshake” plasma
  • Limitations: It generally does not produce the detailed optical reaction curves seen in photo-optical systems

Alternative Methodologies

Modern analyzers are not limited to clotting assays. To perform a full hemostasis profile (including D-Dimer and Factor assays), instruments incorporate Chromogenic and Immunologic technologies

Chromogenic Assays (Colorimetric)

Certain coagulation factors are difficult to measure via clot-based time. Instead, their activity is measured chemically using a synthetic substrate. This is standard for Anti-Xa (Heparin monitoring), Protein C, and Antithrombin assays

  • Principle
    • The reagent contains a synthetic substrate attached to a “chromophore” (usually para-nitroaniline or pNA). When attached, the chromophore is colorless
    • The patient’s enzyme (e.g., activated Factor X) acts as “scissors,” cleaving the substrate
    • Reaction: Upon cleavage, the pNA is released, turning the solution Yellow
  • Measurement: The analyzer measures the absorbance of the yellow color (usually at 405 nm). By Beer’s Law, the intensity of the color is directly proportional to the activity of the enzyme
  • Inverse vs. Direct
    • Direct: More color = More Factor activity (e.g., Protein C)
    • Indirect (Competitive): Used for Antithrombin or Anti-Xa. We add excess Factor Xa; if the patient has high Anti-Xa (heparin), they inhibit the reaction, resulting in less color. Therefore, Less Color = High Heparin

Immunologic Assays (Latex Agglutination)

This technology is required for the D-Dimer assay and Von Willebrand Factor (vWF) antigen testing

  • Principle
    • Microscopic latex beads are coated with a specific monoclonal antibody (e.g., anti-D-dimer)
    • Patient plasma is added. If the antigen (D-Dimer fragment) is present, it binds to the antibodies on the beads, linking them together
    • Agglutination: The beads clump together to form larger complexes
  • Detection
    • Turbidimetry: The analyzer shoots light through the cuvette. As the beads clump, they block more light. The increase in absorbance is proportional to the concentration of D-Dimer

Data Analysis: The Clot Curve

In photo-optical systems, the laboratory scientist must be able to interpret the “Clot Signature” or reaction curve to verify results. The instrument does not simply wait for a clot; it monitors the entire life cycle of the reaction

  • The Phases of the Curve
    • Baseline: The flat line at the beginning. Represents the lag phase where reagents are mixing and the cascade is initiating but no fibrin has formed. Noise here indicates bubbles or dirty cuvettes
    • Acceleration: The slope rises sharply. This represents the “Thrombin Burst” and the rapid polymerization of fibrinogen
    • Plateau: The curve flattens out. Fibrin formation is complete
  • Methods of Calculation
    • Threshold Method: The timer stops when the optical density crosses a fixed value
    • Percentage Detection: The timer stops when the OD reaches 50% of the total change between baseline and plateau
    • Derivative Method (First Derivative): The instrument calculates the speed of the reaction (velocity). The endpoint is defined as the moment of Maximum Velocity (V-max) of clot formation. This is the most robust method against interferences
  • Biphasic Curve: A dangerous error pattern seen in DIC or extreme turbidity. The curve rises, dips, and rises again. The analyzer may “time out” early on the dip, reporting a falsely short PTT. The laboratory scientist must inspect the curve to catch this

Interferences & HIL Checks

Pre-analytical variables are the most common source of error in Coagulation. Automated analyzers perform “HIL Checks” (Hemolysis, Icterus, Lipemia) on every sample by scanning the plasma at multiple wavelengths before adding reagents

  • Hemolysis: Red plasma. Lysis of RBCs releases ADP and membrane phospholipids, which can activate platelets and the coagulation cascade in vitro, causing falsely Shortened PT/PTT. Severe hemolysis can also interfere optically
  • Lipemia: Milky plasma. Causes light scatter. In optical systems, this mimics a clot (high baseline absorbance), leading to errors. Ultracentrifugation is required to clear the lipids (Airfuge)
  • Icterus: Yellow/Orange plasma. Bilirubin absorbs light in the 400–500 nm range. This interferes significantly with Chromogenic assays (which measure yellow color at 405 nm)
  • Probe Integrity: Analyzers use “Liquid Level Sensing” (capacitance or pneumatic) to ensure enough volume exists. If the probe hits foam (bubbles), it may aspirate air, leading to a short sample and a falsely prolonged clotting time